Atopic dermatitis (AD) typically manifests in infancy and is often the first presenter in a series of type 2 inflammatory diseases commonly referred to as “the atopic march”. While novel therapies have been recently made available for adults and teens, the treatment landscape for infants and children is finally catching up. In this multidisciplinary, interprofessional panel featuring allergists, dermatologists, physicians, a PA, eczema educator, and a parent/guardian of a child with AD, experts will discuss the pathophysiology of AD, new and emerging biologics for pediatric AD, and how to approach AD management with an effective team-based strategy. Attend in-person or via simulcast.
Hybrid Satellite Symposium during the AAAAI Annual Meeting
February 24, 2023 – 7:00PM – 8:30PM CST
Upon successful completion of this educational activity, participants should be better able to:
Voluntary Associate Clinical Professor, Allergy & Immunology
Co-Director, AAFA-sponsored Severe Asthma Program
Rady Children’s Hospital
Allergy/Immunology Director, Multidisciplinary Atopic Dermatitis Program
University of California San Diego
President, San Diego Allergy Society
San Diego, CA
Eczema Educator/Lead Clinical Research Coordinator
Rady Children’s Hospital
Director, Grants and Rare Disease
Allergy and Asthma Medical Group and Research Center
Executive Director, San Diego Allergy Society
San Diego, CA
Assistant Professor, Department of Dermatology
University of California San Diego
San Diego, CA
Clinic Coordinator, Multidisciplinary Atopic Dermatitis Program
Rady Children’s Hospital
San Diego, CA
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
